0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Skin Substitutes from Biological Sources Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-0Y17359
Home | Market Reports | Beauty & Fitness| Face & Body Care| Skin & Nail Care
Global Skin Substitutes from Biological Sources Market Research Report 2024
BUY CHAPTERS

Global Skin Substitutes from Biological Sources Market Research Report 2024

Code: QYRE-Auto-0Y17359
Report
April 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Skin Substitutes from Biological Sources Market Size

The global Skin Substitutes from Biological Sources market was valued at US$ 1717 million in 2023 and is anticipated to reach US$ 3712 million by 2030, witnessing a CAGR of 11.8% during the forecast period 2024-2030.

Skin Substitutes from Biological Sources Market

Skin Substitutes from Biological Sources Market

Biological skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
North American market for Skin Substitutes from Biological Sources is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Skin Substitutes from Biological Sources is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Skin Substitutes from Biological Sources in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Skin Substitutes from Biological Sources include Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen, Vericel Corporation, LifeNet Health, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Skin Substitutes from Biological Sources, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Substitutes from Biological Sources.
The Skin Substitutes from Biological Sources market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Skin Substitutes from Biological Sources market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Skin Substitutes from Biological Sources companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Skin Substitutes from Biological Sources Market Report

Report Metric Details
Report Name Skin Substitutes from Biological Sources Market
Accounted market size in 2023 US$ 1717 million
Forecasted market size in 2030 US$ 3712 million
CAGR 11.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Allogeneic Acellular Cells
  • Xenogeneic Cells
  • Allogeneic Cells
  • Autologous Cells
Segment by Application
  • Hospitals
  • Specialty Clinics
  • Wound Care Centers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen, Vericel Corporation, LifeNet Health, MTF Biologics, Arthrex, Wright Medical Group NV (Stryker), Cook Biotech Incorporated, Aroa Biosurgery, Surgalign Holdings, Anika Therapeutics, Forticell Bioscience, MLM Biologics, Promethean LifeSciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Skin Substitutes from Biological Sources company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Skin Substitutes from Biological Sources Market growing?

Ans: The Skin Substitutes from Biological Sources Market witnessing a CAGR of 11.8% during the forecast period 2024-2030.

What is the Skin Substitutes from Biological Sources Market size in 2030?

Ans: The Skin Substitutes from Biological Sources Market size in 2030 will be US$ 3712 million.

Who are the main players in the Skin Substitutes from Biological Sources Market report?

Ans: The main players in the Skin Substitutes from Biological Sources Market are Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen, Vericel Corporation, LifeNet Health, MTF Biologics, Arthrex, Wright Medical Group NV (Stryker), Cook Biotech Incorporated, Aroa Biosurgery, Surgalign Holdings, Anika Therapeutics, Forticell Bioscience, MLM Biologics, Promethean LifeSciences

What are the Application segmentation covered in the Skin Substitutes from Biological Sources Market report?

Ans: The Applications covered in the Skin Substitutes from Biological Sources Market report are Hospitals, Specialty Clinics, Wound Care Centers

What are the Type segmentation covered in the Skin Substitutes from Biological Sources Market report?

Ans: The Types covered in the Skin Substitutes from Biological Sources Market report are Allogeneic Acellular Cells, Xenogeneic Cells, Allogeneic Cells, Autologous Cells

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Substitutes from Biological Sources Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Allogeneic Acellular Cells
1.2.3 Xenogeneic Cells
1.2.4 Allogeneic Cells
1.2.5 Autologous Cells
1.3 Market by Application
1.3.1 Global Skin Substitutes from Biological Sources Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Wound Care Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Skin Substitutes from Biological Sources Market Perspective (2019-2030)
2.2 Global Skin Substitutes from Biological Sources Growth Trends by Region
2.2.1 Global Skin Substitutes from Biological Sources Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Skin Substitutes from Biological Sources Historic Market Size by Region (2019-2024)
2.2.3 Skin Substitutes from Biological Sources Forecasted Market Size by Region (2025-2030)
2.3 Skin Substitutes from Biological Sources Market Dynamics
2.3.1 Skin Substitutes from Biological Sources Industry Trends
2.3.2 Skin Substitutes from Biological Sources Market Drivers
2.3.3 Skin Substitutes from Biological Sources Market Challenges
2.3.4 Skin Substitutes from Biological Sources Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Substitutes from Biological Sources Players by Revenue
3.1.1 Global Top Skin Substitutes from Biological Sources Players by Revenue (2019-2024)
3.1.2 Global Skin Substitutes from Biological Sources Revenue Market Share by Players (2019-2024)
3.2 Global Skin Substitutes from Biological Sources Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Skin Substitutes from Biological Sources Revenue
3.4 Global Skin Substitutes from Biological Sources Market Concentration Ratio
3.4.1 Global Skin Substitutes from Biological Sources Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Substitutes from Biological Sources Revenue in 2023
3.5 Global Key Players of Skin Substitutes from Biological Sources Head office and Area Served
3.6 Global Key Players of Skin Substitutes from Biological Sources, Product and Application
3.7 Global Key Players of Skin Substitutes from Biological Sources, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Substitutes from Biological Sources Breakdown Data by Type
4.1 Global Skin Substitutes from Biological Sources Historic Market Size by Type (2019-2024)
4.2 Global Skin Substitutes from Biological Sources Forecasted Market Size by Type (2025-2030)
5 Skin Substitutes from Biological Sources Breakdown Data by Application
5.1 Global Skin Substitutes from Biological Sources Historic Market Size by Application (2019-2024)
5.2 Global Skin Substitutes from Biological Sources Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Skin Substitutes from Biological Sources Market Size (2019-2030)
6.2 North America Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Skin Substitutes from Biological Sources Market Size by Country (2019-2024)
6.4 North America Skin Substitutes from Biological Sources Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Skin Substitutes from Biological Sources Market Size (2019-2030)
7.2 Europe Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Skin Substitutes from Biological Sources Market Size by Country (2019-2024)
7.4 Europe Skin Substitutes from Biological Sources Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Skin Substitutes from Biological Sources Market Size (2019-2030)
8.2 Asia-Pacific Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Skin Substitutes from Biological Sources Market Size by Region (2019-2024)
8.4 Asia-Pacific Skin Substitutes from Biological Sources Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Skin Substitutes from Biological Sources Market Size (2019-2030)
9.2 Latin America Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Skin Substitutes from Biological Sources Market Size by Country (2019-2024)
9.4 Latin America Skin Substitutes from Biological Sources Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Substitutes from Biological Sources Market Size (2019-2030)
10.2 Middle East & Africa Skin Substitutes from Biological Sources Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Skin Substitutes from Biological Sources Market Size by Country (2019-2024)
10.4 Middle East & Africa Skin Substitutes from Biological Sources Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan (AbbVie)
11.1.1 Allergan (AbbVie) Company Details
11.1.2 Allergan (AbbVie) Business Overview
11.1.3 Allergan (AbbVie) Skin Substitutes from Biological Sources Introduction
11.1.4 Allergan (AbbVie) Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.1.5 Allergan (AbbVie) Recent Development
11.2 AlloSource
11.2.1 AlloSource Company Details
11.2.2 AlloSource Business Overview
11.2.3 AlloSource Skin Substitutes from Biological Sources Introduction
11.2.4 AlloSource Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.2.5 AlloSource Recent Development
11.3 Organogenesis
11.3.1 Organogenesis Company Details
11.3.2 Organogenesis Business Overview
11.3.3 Organogenesis Skin Substitutes from Biological Sources Introduction
11.3.4 Organogenesis Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.3.5 Organogenesis Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Skin Substitutes from Biological Sources Introduction
11.4.4 BD Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.4.5 BD Recent Development
11.5 Smith & Nephew
11.5.1 Smith & Nephew Company Details
11.5.2 Smith & Nephew Business Overview
11.5.3 Smith & Nephew Skin Substitutes from Biological Sources Introduction
11.5.4 Smith & Nephew Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.5.5 Smith & Nephew Recent Development
11.6 Integra LifeSciences
11.6.1 Integra LifeSciences Company Details
11.6.2 Integra LifeSciences Business Overview
11.6.3 Integra LifeSciences Skin Substitutes from Biological Sources Introduction
11.6.4 Integra LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.6.5 Integra LifeSciences Recent Development
11.7 Synthes (Johnson & Johnson)
11.7.1 Synthes (Johnson & Johnson) Company Details
11.7.2 Synthes (Johnson & Johnson) Business Overview
11.7.3 Synthes (Johnson & Johnson) Skin Substitutes from Biological Sources Introduction
11.7.4 Synthes (Johnson & Johnson) Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.7.5 Synthes (Johnson & Johnson) Recent Development
11.8 Axogen
11.8.1 Axogen Company Details
11.8.2 Axogen Business Overview
11.8.3 Axogen Skin Substitutes from Biological Sources Introduction
11.8.4 Axogen Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.8.5 Axogen Recent Development
11.9 Vericel Corporation
11.9.1 Vericel Corporation Company Details
11.9.2 Vericel Corporation Business Overview
11.9.3 Vericel Corporation Skin Substitutes from Biological Sources Introduction
11.9.4 Vericel Corporation Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.9.5 Vericel Corporation Recent Development
11.10 LifeNet Health
11.10.1 LifeNet Health Company Details
11.10.2 LifeNet Health Business Overview
11.10.3 LifeNet Health Skin Substitutes from Biological Sources Introduction
11.10.4 LifeNet Health Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.10.5 LifeNet Health Recent Development
11.11 MTF Biologics
11.11.1 MTF Biologics Company Details
11.11.2 MTF Biologics Business Overview
11.11.3 MTF Biologics Skin Substitutes from Biological Sources Introduction
11.11.4 MTF Biologics Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.11.5 MTF Biologics Recent Development
11.12 Arthrex
11.12.1 Arthrex Company Details
11.12.2 Arthrex Business Overview
11.12.3 Arthrex Skin Substitutes from Biological Sources Introduction
11.12.4 Arthrex Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.12.5 Arthrex Recent Development
11.13 Wright Medical Group NV (Stryker)
11.13.1 Wright Medical Group NV (Stryker) Company Details
11.13.2 Wright Medical Group NV (Stryker) Business Overview
11.13.3 Wright Medical Group NV (Stryker) Skin Substitutes from Biological Sources Introduction
11.13.4 Wright Medical Group NV (Stryker) Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.13.5 Wright Medical Group NV (Stryker) Recent Development
11.14 Cook Biotech Incorporated
11.14.1 Cook Biotech Incorporated Company Details
11.14.2 Cook Biotech Incorporated Business Overview
11.14.3 Cook Biotech Incorporated Skin Substitutes from Biological Sources Introduction
11.14.4 Cook Biotech Incorporated Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.14.5 Cook Biotech Incorporated Recent Development
11.15 Aroa Biosurgery
11.15.1 Aroa Biosurgery Company Details
11.15.2 Aroa Biosurgery Business Overview
11.15.3 Aroa Biosurgery Skin Substitutes from Biological Sources Introduction
11.15.4 Aroa Biosurgery Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.15.5 Aroa Biosurgery Recent Development
11.16 Surgalign Holdings
11.16.1 Surgalign Holdings Company Details
11.16.2 Surgalign Holdings Business Overview
11.16.3 Surgalign Holdings Skin Substitutes from Biological Sources Introduction
11.16.4 Surgalign Holdings Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.16.5 Surgalign Holdings Recent Development
11.17 Anika Therapeutics
11.17.1 Anika Therapeutics Company Details
11.17.2 Anika Therapeutics Business Overview
11.17.3 Anika Therapeutics Skin Substitutes from Biological Sources Introduction
11.17.4 Anika Therapeutics Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.17.5 Anika Therapeutics Recent Development
11.18 Forticell Bioscience
11.18.1 Forticell Bioscience Company Details
11.18.2 Forticell Bioscience Business Overview
11.18.3 Forticell Bioscience Skin Substitutes from Biological Sources Introduction
11.18.4 Forticell Bioscience Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.18.5 Forticell Bioscience Recent Development
11.19 MLM Biologics
11.19.1 MLM Biologics Company Details
11.19.2 MLM Biologics Business Overview
11.19.3 MLM Biologics Skin Substitutes from Biological Sources Introduction
11.19.4 MLM Biologics Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.19.5 MLM Biologics Recent Development
11.20 Promethean LifeSciences
11.20.1 Promethean LifeSciences Company Details
11.20.2 Promethean LifeSciences Business Overview
11.20.3 Promethean LifeSciences Skin Substitutes from Biological Sources Introduction
11.20.4 Promethean LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2019-2024)
11.20.5 Promethean LifeSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Skin Substitutes from Biological Sources Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Allogeneic Acellular Cells
 Table 3. Key Players of Xenogeneic Cells
 Table 4. Key Players of Allogeneic Cells
 Table 5. Key Players of Autologous Cells
 Table 6. Global Skin Substitutes from Biological Sources Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Skin Substitutes from Biological Sources Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Skin Substitutes from Biological Sources Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Skin Substitutes from Biological Sources Market Share by Region (2019-2024)
 Table 10. Global Skin Substitutes from Biological Sources Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Skin Substitutes from Biological Sources Market Share by Region (2025-2030)
 Table 12. Skin Substitutes from Biological Sources Market Trends
 Table 13. Skin Substitutes from Biological Sources Market Drivers
 Table 14. Skin Substitutes from Biological Sources Market Challenges
 Table 15. Skin Substitutes from Biological Sources Market Restraints
 Table 16. Global Skin Substitutes from Biological Sources Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Skin Substitutes from Biological Sources Market Share by Players (2019-2024)
 Table 18. Global Top Skin Substitutes from Biological Sources Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Substitutes from Biological Sources as of 2023)
 Table 19. Ranking of Global Top Skin Substitutes from Biological Sources Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Skin Substitutes from Biological Sources Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Skin Substitutes from Biological Sources, Headquarters and Area Served
 Table 22. Global Key Players of Skin Substitutes from Biological Sources, Product and Application
 Table 23. Global Key Players of Skin Substitutes from Biological Sources, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Skin Substitutes from Biological Sources Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Skin Substitutes from Biological Sources Revenue Market Share by Type (2019-2024)
 Table 27. Global Skin Substitutes from Biological Sources Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Skin Substitutes from Biological Sources Revenue Market Share by Type (2025-2030)
 Table 29. Global Skin Substitutes from Biological Sources Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Skin Substitutes from Biological Sources Revenue Market Share by Application (2019-2024)
 Table 31. Global Skin Substitutes from Biological Sources Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Skin Substitutes from Biological Sources Revenue Market Share by Application (2025-2030)
 Table 33. North America Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Skin Substitutes from Biological Sources Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Skin Substitutes from Biological Sources Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Skin Substitutes from Biological Sources Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Skin Substitutes from Biological Sources Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Skin Substitutes from Biological Sources Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Skin Substitutes from Biological Sources Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Skin Substitutes from Biological Sources Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Skin Substitutes from Biological Sources Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Skin Substitutes from Biological Sources Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Skin Substitutes from Biological Sources Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Skin Substitutes from Biological Sources Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Allergan (AbbVie) Company Details
 Table 49. Allergan (AbbVie) Business Overview
 Table 50. Allergan (AbbVie) Skin Substitutes from Biological Sources Product
 Table 51. Allergan (AbbVie) Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 52. Allergan (AbbVie) Recent Development
 Table 53. AlloSource Company Details
 Table 54. AlloSource Business Overview
 Table 55. AlloSource Skin Substitutes from Biological Sources Product
 Table 56. AlloSource Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 57. AlloSource Recent Development
 Table 58. Organogenesis Company Details
 Table 59. Organogenesis Business Overview
 Table 60. Organogenesis Skin Substitutes from Biological Sources Product
 Table 61. Organogenesis Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 62. Organogenesis Recent Development
 Table 63. BD Company Details
 Table 64. BD Business Overview
 Table 65. BD Skin Substitutes from Biological Sources Product
 Table 66. BD Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 67. BD Recent Development
 Table 68. Smith & Nephew Company Details
 Table 69. Smith & Nephew Business Overview
 Table 70. Smith & Nephew Skin Substitutes from Biological Sources Product
 Table 71. Smith & Nephew Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 72. Smith & Nephew Recent Development
 Table 73. Integra LifeSciences Company Details
 Table 74. Integra LifeSciences Business Overview
 Table 75. Integra LifeSciences Skin Substitutes from Biological Sources Product
 Table 76. Integra LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 77. Integra LifeSciences Recent Development
 Table 78. Synthes (Johnson & Johnson) Company Details
 Table 79. Synthes (Johnson & Johnson) Business Overview
 Table 80. Synthes (Johnson & Johnson) Skin Substitutes from Biological Sources Product
 Table 81. Synthes (Johnson & Johnson) Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 82. Synthes (Johnson & Johnson) Recent Development
 Table 83. Axogen Company Details
 Table 84. Axogen Business Overview
 Table 85. Axogen Skin Substitutes from Biological Sources Product
 Table 86. Axogen Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 87. Axogen Recent Development
 Table 88. Vericel Corporation Company Details
 Table 89. Vericel Corporation Business Overview
 Table 90. Vericel Corporation Skin Substitutes from Biological Sources Product
 Table 91. Vericel Corporation Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 92. Vericel Corporation Recent Development
 Table 93. LifeNet Health Company Details
 Table 94. LifeNet Health Business Overview
 Table 95. LifeNet Health Skin Substitutes from Biological Sources Product
 Table 96. LifeNet Health Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 97. LifeNet Health Recent Development
 Table 98. MTF Biologics Company Details
 Table 99. MTF Biologics Business Overview
 Table 100. MTF Biologics Skin Substitutes from Biological Sources Product
 Table 101. MTF Biologics Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 102. MTF Biologics Recent Development
 Table 103. Arthrex Company Details
 Table 104. Arthrex Business Overview
 Table 105. Arthrex Skin Substitutes from Biological Sources Product
 Table 106. Arthrex Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 107. Arthrex Recent Development
 Table 108. Wright Medical Group NV (Stryker) Company Details
 Table 109. Wright Medical Group NV (Stryker) Business Overview
 Table 110. Wright Medical Group NV (Stryker) Skin Substitutes from Biological Sources Product
 Table 111. Wright Medical Group NV (Stryker) Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 112. Wright Medical Group NV (Stryker) Recent Development
 Table 113. Cook Biotech Incorporated Company Details
 Table 114. Cook Biotech Incorporated Business Overview
 Table 115. Cook Biotech Incorporated Skin Substitutes from Biological Sources Product
 Table 116. Cook Biotech Incorporated Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 117. Cook Biotech Incorporated Recent Development
 Table 118. Aroa Biosurgery Company Details
 Table 119. Aroa Biosurgery Business Overview
 Table 120. Aroa Biosurgery Skin Substitutes from Biological Sources Product
 Table 121. Aroa Biosurgery Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 122. Aroa Biosurgery Recent Development
 Table 123. Surgalign Holdings Company Details
 Table 124. Surgalign Holdings Business Overview
 Table 125. Surgalign Holdings Skin Substitutes from Biological Sources Product
 Table 126. Surgalign Holdings Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 127. Surgalign Holdings Recent Development
 Table 128. Anika Therapeutics Company Details
 Table 129. Anika Therapeutics Business Overview
 Table 130. Anika Therapeutics Skin Substitutes from Biological Sources Product
 Table 131. Anika Therapeutics Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 132. Anika Therapeutics Recent Development
 Table 133. Forticell Bioscience Company Details
 Table 134. Forticell Bioscience Business Overview
 Table 135. Forticell Bioscience Skin Substitutes from Biological Sources Product
 Table 136. Forticell Bioscience Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 137. Forticell Bioscience Recent Development
 Table 138. MLM Biologics Company Details
 Table 139. MLM Biologics Business Overview
 Table 140. MLM Biologics Skin Substitutes from Biological Sources Product
 Table 141. MLM Biologics Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 142. MLM Biologics Recent Development
 Table 143. Promethean LifeSciences Company Details
 Table 144. Promethean LifeSciences Business Overview
 Table 145. Promethean LifeSciences Skin Substitutes from Biological Sources Product
 Table 146. Promethean LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2019-2024) & (US$ Million)
 Table 147. Promethean LifeSciences Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Skin Substitutes from Biological Sources Picture
 Figure 2. Global Skin Substitutes from Biological Sources Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Skin Substitutes from Biological Sources Market Share by Type: 2023 VS 2030
 Figure 4. Allogeneic Acellular Cells Features
 Figure 5. Xenogeneic Cells Features
 Figure 6. Allogeneic Cells Features
 Figure 7. Autologous Cells Features
 Figure 8. Global Skin Substitutes from Biological Sources Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Skin Substitutes from Biological Sources Market Share by Application: 2023 VS 2030
 Figure 10. Hospitals Case Studies
 Figure 11. Specialty Clinics Case Studies
 Figure 12. Wound Care Centers Case Studies
 Figure 13. Skin Substitutes from Biological Sources Report Years Considered
 Figure 14. Global Skin Substitutes from Biological Sources Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Skin Substitutes from Biological Sources Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Skin Substitutes from Biological Sources Market Share by Region: 2023 VS 2030
 Figure 17. Global Skin Substitutes from Biological Sources Market Share by Players in 2023
 Figure 18. Global Top Skin Substitutes from Biological Sources Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Substitutes from Biological Sources as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Skin Substitutes from Biological Sources Revenue in 2023
 Figure 20. North America Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Skin Substitutes from Biological Sources Market Share by Country (2019-2030)
 Figure 22. United States Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Skin Substitutes from Biological Sources Market Share by Country (2019-2030)
 Figure 26. Germany Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Skin Substitutes from Biological Sources Market Share by Region (2019-2030)
 Figure 34. China Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Skin Substitutes from Biological Sources Market Share by Country (2019-2030)
 Figure 42. Mexico Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Skin Substitutes from Biological Sources Market Share by Country (2019-2030)
 Figure 46. Turkey Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Skin Substitutes from Biological Sources Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Allergan (AbbVie) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 50. AlloSource Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 51. Organogenesis Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 52. BD Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 53. Smith & Nephew Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 54. Integra LifeSciences Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 55. Synthes (Johnson & Johnson) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 56. Axogen Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 57. Vericel Corporation Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 58. LifeNet Health Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 59. MTF Biologics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 60. Arthrex Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 61. Wright Medical Group NV (Stryker) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 62. Cook Biotech Incorporated Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 63. Aroa Biosurgery Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 64. Surgalign Holdings Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 65. Anika Therapeutics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 66. Forticell Bioscience Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 67. MLM Biologics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 68. Promethean LifeSciences Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2019-2024)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Sun Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37N3924
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Facial Skincare Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35H8470
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Facial Moisturizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N8391
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Face Cleansing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11Q1907
Wed Sep 10 00:00:00 UTC 2025

Add to Cart